Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Tunable bio-inspired hybrid hydrogels reprogram stem cell-derived extracellular vesicles for superior wound regeneration.

Lai YH., Suhana, Lee SS., Yang KH., Wu YC., Atturu P.

Animal Study on Chronic Wound, published in Biomater Sci (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Biomater Sci (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
42383565
DOI
10.1039/d6bm00097e

Abstract (original English)

Clinical translation of adipose-derived stem cell (ADSC)-derived extracellular vesicles (EVs) for cutaneous regeneration is challenged by variable secretion levels, heterogeneous molecular cargo, and inconsistent therapeutic potency. Here, we developed a mechanically tunable and biomolecularly instructive photocurable hybrid hydrogel (GelMA/HAMA/PEGDA) that serves both as a 3D culture microenvironment for ADSCs and as an EV-delivery scaffold. Systematic screening of PEGDA-controlled crosslinking identified GH11P (97% [15% GelMA : 1% HAMA = 1 : 1 (v/v)] + 3% PEGDA) as a formulation with balanced stiffness, controlled degradation, and cytocompatibility, supporting EV production under 3D culture. Multi-omics profiling suggested that EVs produced in this 3D matrix (3D-hcEVs) exhibit regenerative-associated signatures, including ECM-integrin interactions, focal adhesion-related pathways, PI3K-AKT signaling, and a keratin-enriched proteomic signature compared with dish-cultured EVs (dcEVs). Additional in vitro validation showed that 3D-hcEVs enhanced HaCaT migration and more strongly increased p-AKT/AKT than dcEVs at 30 and 60 min. An NTA-based in vitro release assay further demonstrated partial, sustained EV release from GH11P over 7 days. In a full-thickness dorsal wound model, GH11P scaffolds loaded with 3D-hcEVs accelerated wound closure compared with dcEV-loaded scaffolds and hy

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HydrogelsWound HealingExtracellular VesiclesAnimalsHumansStem CellsPolyethylene GlycolsAdipose Tissue

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research